3Q21 Financial Results Conference Call & Webcast November 9, 2021 Introduction Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 relating to preclinical and clinical development of our product candidates, the timing and reporting of results from preclinical studies and clinical trials, the prospects and timing of the potential regulatory approval of our product candidates, commercialization plans, man ...

Ocugen, Inc. (NASDAQ:OCGN) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Shankar Musunuri – CEO Sanjay Subramanian – CFO Ken Inchausti – Head of Investor Relations Conference Call Participants Keay Nakae – Chardan Zegbeh Jallah – Roth Capital Robert Leboyer – Noble Capital Sean Lee – HC Wainwright Operator Good morning, and welcome to the Ocugen Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the present ...

Our Mission is to Develop Gene Therapies to Cure Blindness Diseases and Develop a Vaccine to Save Lives from COVID-19 NASDAQ: OCGN Corporate Deck: August 2021 Forward Looking Statement This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our business strategy, future results of operations and financial position, prospective products, pro ...

Ocugen Inc. (NASDAQ:OCGN) Q2 2021 Earnings Conference Call August 6, 2021 8:30 AM ET Company Participants Shankar Musunuri - Chairman, Chief Executive Officer Sanjay Subramanian - Chief Financial Officer, Head of Corporate Development Ken Inchausti - Head of Investor Relations and Communications Conference Call Participants Keay Nakae - Chardan Robert LeBoyer - Noble Capital Swayampakula Ramakanth - HC Wainwright Kristen Kluska - Cantor Fitzgerald Operator Good morning and welcome to the Ocugen conference ...

Our Mission is to Develop Gene Therapies to Cure Blindness Diseases and Develop a Vaccine to Save Lives from COVID-19 NASDAQ: OCGN Corporate Deck: May 2021 Forward Looking Statement This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our business strategy, future results of operations and financial position, prospective products, produc ...

Ocugen, Inc. (NASDAQ:OCGN) Q1 2021 Earnings Conference Call May 7, 2021 9:00 AM ET Company Participants Lisa DeScenza – Vice President-Integrated Communications-LaVoie Health Science Shankar Musunuri – Chairman, Chief Executive Officer and Co-Founder Sanjay Subramanian – Chief Financial Officer and Head-Corporate Development Conference Call Participants Keay Nakae – Chardan Zegbeh Jallah – ROTH Capital Robert LeBoyer – Noble Capital Swayampakula Ramakanth – H.C. Wainwright Kristen Kluska – Cantor Fitzgerald ...

Ocugen, Inc. (NASDAQ:OCGN) Q4 2020 Earnings Conference Call March 18, 2021 8:30 AM ET Company Participants Lisa DeScenza – Vice President of Integrated Communications, LaVoie Health Science Shankar Musunuri – Chairman and Chief Executive Officer Sanjay Subramanian – Chief Financial Officer and Head of Corporate Development Conference Call Participants Keay Nakae – Chardan Zegbeh Jallah – ROTH Capital Partners Swayampakula Ramakanth – H.C. Wainwright Operator Good morning, and welcome to the Ocugen Conferenc ...

Our Mission is to Develop Gene Therapies to Cure Blindness Diseases and Develop a Vaccine to Save Lives from COVID-19 NASDAQ: OCGN Corporate Deck: March 2021 Forward Looking Statement This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our business strategy, future results of operations and financial position, prospective products, prod ...

Our Mission is to Develop Gene Therapies to Cure Blindness Diseases and Develop a Vaccine to fight COVID-19 NASDAQ: OCGN Corporate Deck: January 2021 Forward Looking Statement This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our business strategy, future results of operations and financial position, prospective products, product appr ...

Ocugen, Inc. (NASDAQ:OCGN) Q2 2020 Results Conference Call August 14, 2020 8:30 AM ET Company Participants Lisa DeScenza - VP of Integrated Communications, LaVoie Health Science Shankar Musunuri - Chairman and CEO Sanjay Subramanian - CFO Mohamed Genead - Acting CMO and Chair of Scientific Advisory Board Conference Call Participants Keay Nakae - Chardan Ramakanth Swayampakula - H.C. Wainwright Kristen Kluska - Cantor Fitzgerald Operator Good morning and welcome to the Ocugen Conference Call. [Operator Instr ...